WALTHAM, Mass.--(BUSINESS WIRE)--Sep. 15, 2009-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has appointed Marc N. Casper president, chief executive officer and a director of the company, effective October 15, 2009. Casper currently serves as executive vice president and chief operating officer. This announcement follows the decision of Marijn E. Dekkers to resign as president, chief executive officer and a member of the board, in order to become chief executive officer of Bayer AG, a global leader in healthcare, nutrition and high-tech materials based in Germany.
Jim Manzi, chairman of the board, said, “Marc’s strong leadership at Thermo Fisher over the past eight years and his achievements both here and in other companies make him the natural choice to lead the company going forward. We are delighted that he will take on this new role. With our industry-leading position, commitment to world-class innovation and the most talented employees in the industry, we believe that the company is well-prepared for this transition and well-positioned to capitalize on new opportunities for growth. On behalf of the entire board of directors, we thank Marijn for his dedication to Thermo Fisher over the last nine years. Marijn has led the company through a period of exciting growth and has built a strong foundation for future success.”
“My years at Thermo Fisher have been some of the best in my career, and I thank our employees, the leadership team and the board for working with me so diligently to achieve our mutual goals for the company,” said Mr. Dekkers. “Having accomplished so much together, it’s now time for me to move on to a new role, and I’m looking forward to the challenges of the next phase of my career. I feel good about my move at this time because the company is very strong financially and, in Marc’s capable hands and with the continued support of our employees, has more growth prospects than ever.”
Casper said, “I have developed great respect for the knowledge and focus of our employees during my time at Thermo Fisher, and look forward to working with the leadership team and the board in my new role. Thanks to the successful execution of our strategy, demonstrated by our excellent financial track record, we have been able to deliver solid operating performance despite challenging economic conditions. We will work to continue to execute on our strategy for growth and success.”
Outlook Affirmed
The company today reaffirmed its full year 2009 outlook, as last updated on July 23, 2009, and expects to achieve annual revenues of $9.80 to $10.10 billion and adjusted earnings per share (EPS) of $2.85 to $3.10 for the year.
Adjusted EPS is a non-GAAP measure that excludes certain items detailed later in this press release under the heading “Use of Non-GAAP Financial Measures.”
Biography
Casper has served as executive vice president and chief operating officer of Thermo Fisher since May 2008. Prior to being named COO, Casper served as president of Thermo Fisher’s analytical technologies businesses following the merger of Thermo Electron and Fisher Scientific in November 2006. Casper joined the company in December 2001 as president of its Life and Laboratory Sciences Sector. Previously, Casper served as president, chief executive officer and a director of Kendro Laboratory Products. Before Kendro, he was president-Americas for Dade Behring Inc. Casper began his career at Bain & Company as a strategy consultant and later joined Bain Capital, where he oversaw business development, strategy and business integration in select companies owned by Bain. Casper earned an MBA with high distinction from Harvard Business School, and is a graduate of Wesleyan University, where he received a bachelor’s degree in economics.
No comments:
Post a Comment